Yes, Prolia Is Given as a Shot
Prolia (denosumab) is administered as a subcutaneous injection, typically every six months. A healthcare provider injects it under the skin in the upper arm, upper thigh, or abdomen using a pre-filled syringe.[1]
How Is Prolia Administered?
Patients receive Prolia at a doctor's office or clinic. The 60 mg dose takes about 15 seconds to inject. It's not self-administered at home, unlike some other osteoporosis treatments.[1][2]
Why a Shot Instead of a Pill?
Prolia targets RANKL protein to slow bone loss, requiring injection for direct bloodstream delivery and high bioavailability. Oral bisphosphonates like Fosamax can be taken as pills but have lower absorption rates.[1][3]
How Often Do You Get Prolia Shots?
Dosing is twice a year, starting with a baseline check of calcium levels and kidney function. Missing a dose requires rescheduling within weeks to maintain protection against fractures.[1]
Common Side Effects from the Injection
Injection site reactions like pain, redness, or itching affect about 8% of users. Other risks include low calcium, jaw bone problems (osteonecrosis), or unusual thigh fractures—monitored closely during treatment.[1][2]
Prolia vs. Other Osteoporosis Treatments
| Treatment | Form | Frequency | Key Difference |
|-----------|------|-----------|---------------|
| Prolia | Subcutaneous shot | Every 6 months | Biologic; higher adherence due to fewer doses |
| Reclast (zoledronic acid) | IV infusion | Once yearly | Requires clinic visit; longer procedure |
| Fosamax (alendronate) | Pill | Daily/weekly | Convenient but GI side effects common |
| Forteo (teriparatide) | Daily self-injection | Daily | Anabolic; builds new bone |
Prolia suits those needing strong, infrequent treatment but not dialysis patients due to kidney risks.[1][3]
Who Makes Prolia and Any Patent Concerns?
Amgen manufactures Prolia. U.S. patents on the core formulation expire around 2025-2030, with biosimilar challenges possible afterward—check DrugPatentWatch.com for updates on litigation and entry dates.[4]
[1] Prolia Prescribing Information, Amgen. https://www.pi.amgen.com/unitedstates/prolia/pihcpenglish.pdf
[2] FDA Label for Denosumab. https://www.accessdata.fda.gov/drugsatfdadocs/label/2010/125320s0079lbl.pdf
[3] American College of Rheumatology Osteoporosis Guidelines. https://rheumatology.org/osteoporosis-guideline
[4] DrugPatentWatch.com - Prolia Patents. https://www.drugpatentwatch.com/p/tradename/PROLI